Prelude Therapeutics Inc (PRLD) insider trading
Every open-market stock purchase and sale by Prelude Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $35M over the last 12 months (3 buys).
- Last insider buy: Baker Bros. Advisors LP (Insider), $9.5M, 5 months ago.
Last 12 months: insiders bought $35M (3 buys) and sold $0 (0 sales). Last close $4.11 on Jun 11, 2026.
Recent PRLD insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 9, 2026 | Katina Dorton (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Baker Bros. Advisors LP (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Martin Babler (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Paul A Friedman (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Victor Sandor (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | David P Bonita (Insider) | Bought (not open market) | — |
| May 1, 2026 | Charles Q Morris (C-suite exec) | Bought (not open market) | $2.1M |
| Apr 27, 2026 | Ra Capital Management L.p. (Insider) | Bought (not open market) | $141 |
| Apr 21, 2026 | Baker Bros. Advisors LP (Insider) | Bought | $9.5M |
| Apr 21, 2026 | David P Bonita (10% owner) | Bought | $7.5M |
| Apr 21, 2026 | Orbimed Advisors LLC (10% owner) | Bought | $7.5M |
| Apr 21, 2026 | David P Bonita (10% owner) | Bought | $5M |
| Apr 21, 2026 | Orbimed Advisors LLC (10% owner) | Bought | $5M |
| Apr 21, 2026 | Baker Bros. Advisors LP (Insider) | Bought | $509K |
| Feb 4, 2026 | Andrew Combs (C-suite exec) | Bought (not open market) | — |
| Feb 4, 2026 | Krishna Vaddi (CEO) | Bought (not open market) | — |
| Feb 4, 2026 | Peggy Scherle (C-suite exec) | Bought (not open market) | — |
| Feb 4, 2026 | Bryant David Lim (CFO) | Bought (not open market) | — |
| Nov 5, 2025 | Victor Sandor (Insider) | Bought (not open market) | — |
| Oct 17, 2025 | Katina Dorton (Insider) | Bought (not open market) | — |
| Oct 4, 2025 | Jane Huang (C-suite exec) | Sold (not open market) | $4.9K |
| Oct 4, 2025 | Jane Huang (C-suite exec) | Bought (not open market) | — |
Who's trading PRLD
- David P Bonita, Insider: bought $12.5M (2 buys), last Jun 9, 2026
- Victor Sandor, Insider: other filings, last Jun 9, 2026
- Katina Dorton, Insider: other filings, last Jun 9, 2026
- Paul A Friedman, Insider: other filings, last Jun 9, 2026
- Baker Bros. Advisors LP, Insider: bought $10M (2 buys), last Jun 9, 2026
- Martin Babler, Insider: other filings, last Jun 9, 2026
- Charles Q Morris, C-suite exec: other filings, last May 1, 2026
- Ra Capital Management L.p., Insider: other filings, last Apr 27, 2026
- Orbimed Advisors LLC, 10% owner: bought $12.5M (2 buys), last Apr 21, 2026
- Krishna Vaddi, CEO: other filings, last Feb 4, 2026
- Andrew Combs, C-suite exec: other filings, last Feb 4, 2026
- Bryant David Lim, CFO: other filings, last Feb 4, 2026
- Peggy Scherle, C-suite exec: other filings, last Feb 4, 2026
- Jane Huang, C-suite exec: other filings, last Oct 4, 2025
Get free alerts when an insider at Prelude Therapeutics Inc files a new trade →